China’s Shinopharm vaccine gets emergency use authorisation in Nepal

China has decided to provide 500,000 doses of BBIBP-CorV vaccine, developed by Sinopharm, under grant assistance.

The Department of Drug Administration, the national drug regulatory authority, has granted emergency use approval to a Covid-19 vaccine developed by the Beijing Institute of Biological Products Co Ltd (BIBP) in China under Sinopharm.